General Catalyst's Summa Bet: Heads GC Wins, Tails Patients Lose

I spell out exactly why the hospital acquisition game—because that's all it is to the PE and VC bros, a damn game—is a gold mine when they crank the leveraged buyout machine.

Welcome to AI Health Uncut, a brutally honest newsletter on AI, innovation, and the state of the healthcare market. If you’d like to sign up to receive issues over email, you can do so here.

First, a quick reminder about a couple of events I’ll be attending this month. I always look forward to meeting fellow healthcare AI enthusiasts, so if you’re at any of these, please stop by and say hello.

🔵 On October 19–21, 2025, I will be attending HLTH USA in Las Vegas, NV — as an influencer, no less (don’t ask 🙄). Use my discount code if you’d also like to attend, and save $250: “H25_POLEVIKOV”.

🔵 On October 28, 2025, I will be speaking at the Health AI Summit in Albuquerque, NM.

As you are well aware, these research and investigations are time- and labor-intensive. I’m a one-man operation. My Founding Members Club of (currently) 19 is what I heavily rely on for resources to conduct these kinds of thorough investigations. If you’d like to become a Founding Member of the AI Health Uncut community, you can join through this link. (Substack may ask you to enter your email first before taking you to the payment page.) You’ll be making a real impact, helping me continue to challenge the system and push for better outcomes in healthcare through AI, technology, policy, and beyond.

After almost two years of back-and-forth, after vicious fights by advocacy groups and reluctant pushback from analysts like me, General Catalyst’s Summa Health deal has finally been rubber-stamped. I’m honestly speechless. From the start, I’ve been shouting about the most elementary, almost laughably obvious asymmetric payoff math — rigged entirely in favor of the acquirer — because of the special structure of this leveraged-debt buyout.

And of course it’s Hemant Taneja, the self-styled digital health mafia boss, who had the audacity and narcissism to name the acquisition shell HATCo after his own damn initials. It’s like he’s spitting in the face of regulators, physicians, and patients alike, daring anyone to call it out.

How could no one see this manipulation? I have no idea. But I’ll break it down: the math is brutally simple. The House always wins. In this case, the House is Hemant Taneja and General Catalyst.

General Catalyst’s audacious acquisition of Summa Health through its shell company “Health Assurance Transformation Corporation” (HATCo) is a masterclass in a heads-I-win, tails-you-lose deal. As someone who’s watched this saga unfold with equal parts fascination and outrage, I won’t mince words: this looks less like a bold healthcare “transformation” and more like a VC firm rigging the game in its favor, regardless of how the patients or the community fare.

Summa Health is a proud Akron, Ohio nonprofit health system now being devoured by a Silicon Valley venture capital outfit that literally created a shell corporation to pull off a hospital buyout it could not otherwise afford. As I said, GC’s CEO Hemant Taneja even cheekily named it HATCo (his initials – how fitting). And despite all the friendly press releases about “long-term commitment” and “community-based, lifelong healthcare,” this deal’s structure screams private equity playbook, no matter GC’s protestations. (Marc Harrison, HATCo’s co-founder, insists “this is neither a VC nor a private equity play” – forgive my skepticism 🙄.)

I explore the two big reasons this deal stinks:

1️⃣ First, the deal’s asymmetric payoff structure means General Catalyst profits no matter what happens to Summa Health or its patients.

2️⃣ Second, the broader context reveals General Catalyst is lunging outside its venture wheelhouse – buying a hospital like a wannabe private equity shop – to distract from a dismal decade of digital health failures and lousy returns.

1. The Asymmetric Payoff: A Rigged Bet Where GC Always Wins